ibandronic acid has been researched along with Back Pain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dorst, A; Faber, H; Ibach, K; Preuss, J; Ringe, JD | 1 |
Dorst, A; Faber, H; Ibach, K; Ringe, JD; Sorenson, F | 1 |
2 trial(s) available for ibandronic acid and Back Pain
Article | Year |
---|---|
Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis.
Topics: Aged; Back Pain; Bone Density; Calcaneus; Diphosphonates; Drug Administration Schedule; Female; Femur Neck; Glucocorticoids; Humans; Hydroxycholecalciferols; Ibandronic Acid; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Prospective Studies; Spinal Fractures | 2003 |
Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study.
Topics: Aged; Back Pain; Body Height; Bone Density; Diphosphonates; Drug Administration Schedule; Female; Glucocorticoids; Humans; Hydroxycholecalciferols; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Osteoporosis; Spinal Fractures | 2003 |